NPI: 1407227945 · EAGAN, MN 55122 · Clinical Social Worker · NPI assigned 10/09/2015
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 10/09/2015 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,317 | $139K |
| 2019 | 9,120 | $406K |
| 2020 | 6,890 | $192K |
| 2021 | 17,426 | $307K |
| 2022 | 45,054 | $632K |
| 2023 | 39,997 | $230K |
| 2024 | 20,009 | $84K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8,704 | 8,393 | $478K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9,395 | 8,861 | $449K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7,162 | 6,686 | $379K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 7,449 | 6,463 | $186K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5,283 | 5,068 | $159K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7,411 | 6,445 | $77K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,970 | 1,926 | $58K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6,043 | 5,720 | $56K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3,632 | 3,513 | $36K |
| 90674 | 1,950 | 1,870 | $27K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,345 | 1,151 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 332 | 327 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,218 | 584 | $10K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 116 | 114 | $9K |
| 90686 | 750 | 731 | $8K | |
| 0004A | 218 | 198 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 75 | 66 | $3K |
| 86580 | 341 | 308 | $3K | |
| 90682 | 61 | 58 | $2K | |
| 0071A | 55 | 52 | $2K | |
| 0072A | 34 | 33 | $1K | |
| 0001A | 34 | 34 | $1K | |
| 99401 | 46 | 46 | $1K | |
| 0002A | 28 | 27 | $894.36 | |
| 81002 | 408 | 394 | $875.88 | |
| 90662 | 18 | 18 | $301.84 | |
| G0008 | Administration of influenza virus vaccine | 44 | 44 | $222.54 |
| 1036F | 19,694 | 18,440 | $0.00 | |
| 3074F | 16,300 | 15,400 | $0.00 | |
| 3008F | 9,076 | 8,557 | $0.00 | |
| 3079F | 2,128 | 2,038 | $0.00 | |
| 3075F | 682 | 659 | $0.00 | |
| 3080F | 55 | 54 | $0.00 | |
| 1160F | 10,841 | 10,181 | $0.00 | |
| 3078F | 11,661 | 11,051 | $0.00 | |
| 1159F | 16,188 | 15,233 | $0.00 | |
| 3077F | 66 | 64 | $0.00 |